Status:
COMPLETED
Remotely Observed Methadone Evaluation
Lead Sponsor:
Sonara Health
Collaborating Sponsors:
Oregon Health and Science University
Stanford University
Conditions:
Opioid Use Disorder
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Opioid addiction, which affects 16 million individuals worldwide, can be treated using methadone, a proven and effective opioid medication for treating OUD that extends retention in care, reduces mort...
Eligibility Criteria
Inclusion
- Receiving methadone for the treatment of opioid use disorder
Exclusion
- Patients with \>13 take-homes
- Patients with positive toxicology results in last 30-60 days
- Patients involved with drug court ineligible for take-homes
- Patients without adequate access to technology
- Patients with \<30 days in treatment
- Patients with mental health instability
- Patients with recent diversion attempts
- Patients using buprenorphine for agonist therapy
- Patients guest dosing at another clinic during trial period
Key Trial Info
Start Date :
September 25 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 2 2022
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT06200740
Start Date
September 25 2022
End Date
December 2 2022
Last Update
January 11 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Adapt - Roseburg
Roseburg, Oregon, United States, 97470